These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 8452475

  • 1. In vitro kinetics of styrene and styrene oxide metabolism in rat, mouse, and human.
    Mendrala AL, Langvardt PW, Nitschke KD, Quast JF, Nolan RJ.
    Arch Toxicol; 1993; 67(1):18-27. PubMed ID: 8452475
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
    Csanády GA, Guengerich FP, Bond JA.
    Carcinogenesis; 1992 Jul; 13(7):1143-53. PubMed ID: 1638680
    [Abstract] [Full Text] [Related]

  • 3. Kinetic modeling of beta-chloroprene metabolism: I. In vitro rates in liver and lung tissue fractions from mice, rats, hamsters, and humans.
    Himmelstein MW, Carpenter SC, Hinderliter PM.
    Toxicol Sci; 2004 May; 79(1):18-27. PubMed ID: 14976339
    [Abstract] [Full Text] [Related]

  • 4. Kinetics of propylene oxide metabolism in microsomes and cytosol of different organs from mouse, rat, and humans.
    Faller TH, Csanády GA, Kreuzer PE, Baur CM, Filser JG.
    Toxicol Appl Pharmacol; 2001 Apr 01; 172(1):62-74. PubMed ID: 11264024
    [Abstract] [Full Text] [Related]

  • 5. A toxicokinetic model for styrene and its metabolite styrene-7,8-oxide in mouse, rat and human with special emphasis on the lung.
    Csanády GA, Kessler W, Hoffmann HD, Filser JG.
    Toxicol Lett; 2003 Feb 18; 138(1-2):75-102. PubMed ID: 12559694
    [Abstract] [Full Text] [Related]

  • 6. Research strategy for assessing target tissue dosimetry of 1,3-butadiene in laboratory animals and humans.
    Bond JA, Csanády GA, Leavens T, Medinsky MA.
    IARC Sci Publ; 1993 Feb 18; (127):45-55. PubMed ID: 8070886
    [Abstract] [Full Text] [Related]

  • 7. Hepatic and extrahepatic metabolism of 14C-styrene oxide.
    Ryan AJ, James MO, Ben-Zvi Z, Law FC, Bend JR.
    Environ Health Perspect; 1976 Oct 18; 17():135-44. PubMed ID: 1026399
    [Abstract] [Full Text] [Related]

  • 8. Drug metabolism in man and its relationship to that in three rodent species: monooxygenase, epoxide hydrolase, and glutathione S-transferase activities in subcellular fractions of lung and liver.
    Lorenz J, Glatt HR, Fleischmann R, Ferlinz R, Oesch F.
    Biochem Med; 1984 Aug 18; 32(1):43-56. PubMed ID: 6541908
    [Abstract] [Full Text] [Related]

  • 9. Effects of model traumatic injury on hepatic drug metabolism in the rat. VI. Major detoxification/toxification pathways.
    Griffeth LK, Rosen GM, Rauchman EJ.
    Drug Metab Dispos; 1987 Aug 18; 15(6):749-59. PubMed ID: 2893698
    [Abstract] [Full Text] [Related]

  • 10. A physiologic pharmacokinetic model for styrene and styrene-7,8-oxide in mouse, rat and man.
    Csanády GA, Mendrala AL, Nolan RJ, Filser JG.
    Arch Toxicol; 1994 Aug 18; 68(3):143-57. PubMed ID: 8024461
    [Abstract] [Full Text] [Related]

  • 11. Estimation of the styrene 7,8-oxide-detoxifying potential of epoxide hydrolase in glutathione-depleted, perfused rat livers.
    Smith BR, Van Anda J, Fouts JR, Bend JR.
    J Pharmacol Exp Ther; 1983 Nov 18; 227(2):491-8. PubMed ID: 6631727
    [Abstract] [Full Text] [Related]

  • 12. Kinetic behaviour of microsomal styrene monooxygenase and styrene epoxide hydratase in different animal species.
    Belvedere G, Cantoni L, Facchinetti T, Salmona M.
    Experientia; 1977 Jun 15; 33(6):708-9. PubMed ID: 891719
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of ethylene and ethylene oxide in subcellular fractions of lungs and livers of male B6C3F1 mice and male fischer 344 rats and of human livers.
    Li Q, Csanády GA, Kessler W, Klein D, Pankratz H, Pütz C, Richter N, Filser JG.
    Toxicol Sci; 2011 Oct 15; 123(2):384-98. PubMed ID: 21785163
    [Abstract] [Full Text] [Related]

  • 14. Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis.
    Oesch F, Protić-Sabljić M, Friedberg T, Klimisch HJ, Glatt HR.
    Carcinogenesis; 1983 Aug 15; 4(8):1031-8. PubMed ID: 6347425
    [Abstract] [Full Text] [Related]

  • 15. Metabolic inactivation of five glycidyl ethers in lung and liver of humans, rats and mice in vitro.
    Boogaard PJ, de Kloe KP, Bierau J, Kuiken G, Borkulo PE, Watson WP, van Sittert NJ.
    Xenobiotica; 2000 May 15; 30(5):485-502. PubMed ID: 10875682
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of lindane treatment on drug metabolizing enzymes and liver weight of CF1 mice in which it evoked hepatomas and in non-susceptible rodents.
    Oesch F, Friedberg T, Herbst M, Paul W, Wilhelm N, Bentley P.
    Chem Biol Interact; 1982 May 15; 40(1):1-14. PubMed ID: 6176340
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.